Choosing, not ranking
There is no shortage of places offering personalized compounded semaglutide online, and no list of the best ones would be honest, because the qualities that matter are published facts a reader can check rather than opinions a guide can hold. This guide gives the checks, drawn from the FDA’s BeSafeRx campaign, the FDA’s statement on unapproved GLP-1 drugs, the FDA’s compounding questions and answers and LegitScript’s published certification standards, then adds the questions that are specific to semaglutide, the red flags to walk away from, and a way to read a price. It names no providers. Bodi Envi appears at the end as one labelled example of what the checks look like against a platform’s own published statements.
This is general information and not medical advice. Personalized Compounded semaglutide is not FDA-approved and is not equivalent to Wegovy® or Ozempic®, and the FDA’s position is that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. Whether treatment is appropriate for you is a decision for a licensed provider.
What to verify first
Five things, each with its source.
A licensed provider who evaluates you. The FDA’s GLP-1 statement advises patients to obtain a prescription from their doctor, and its BeSafeRx page says a safe online pharmacy always requires a doctor’s prescription. Under the federal law the FDA describes, a 503A pharmacy compounds only on a patient-specific prescription. A provider that is chosen well names its clinical organization, describes the assessment a licensed clinician reviews, and says in writing that completing the assessment does not guarantee a prescription.
A state-licensed pharmacy you can name. The FDA’s advice is to fill the prescription at a state-licensed pharmacy, and BeSafeRx says a safe pharmacy is licensed with a state board of pharmacy and has a licensed pharmacist to answer questions. The FDA’s questions and answers page warns that buyers of compounded drugs online may not know the identity of the compounder. Ask which pharmacy prepares the medication and in which state it is licensed, and expect the pharmacy’s name and contact details on your prescription label.
A LegitScript listing. LegitScript’s healthcare certification standards require adequate licensure for the services offered and the jurisdictions served, dispensing only on a valid prescription, privacy compliance, no recent or repeated disciplinary action, and accurate, transparent, non-misleading practices and advertising. Its website checker at legitscript.com/websites is where a domain’s status is looked up; a badge is a claim and the checker is the verification. Certification is not FDA approval of any medication.
Published pricing, with what it includes. A price should be visible before any payment details are entered, and it should say whether it covers the assessment, the provider review, ongoing messaging and the medication, or only some of those.
Published cancellation and refund terms. What is refundable, when, and what happens to medication already dispensed should be in a policy you can read before ordering.
Questions specific to semaglutide
Three questions belong to semaglutide in particular, and a good provider can answer each.
Is the product semaglutide base? The FDA’s statement says some compounders have sold salt forms, semaglutide sodium and semaglutide acetate, which are different active ingredients from the one in the approved products, for which the agency has no data on equivalence and no lawful basis for use in compounding. The pharmacy label should name the active ingredient, and the pharmacy can confirm it.
How is the dose measured? Personalized Compounded semaglutide is typically dispensed as a vial of solution measured with a syringe, at a concentration that can differ between pharmacies. The FDA’s statement reports adverse events, some requiring hospitalization, linked to patients measuring incorrect doses and providers miscalculating them. A good provider gives measuring instructions on the pharmacy label, has a clinician available to answer questions after the medication arrives, and never leaves the conversion from milligrams to syringe units to guesswork.
What is the dosing plan and why? The Wegovy® label describes a starting dose of 0.25 mg once weekly rising in four week steps, with the escalation there to reduce gastrointestinal side effects, and it allows a provider to slow it. The FDA’s statement reports adverse events in patients given personalized compounded semaglutide in doses beyond what the approved label describes. A provider’s plan may differ from the label, but a good provider can tell you how and why, and does not raise the dose faster or higher than the label without a reason.
Questions to ask before you order
The checks and the semaglutide questions above turn into a short list a provider should be able to answer from its own published pages, without a phone call. Which clinical organization reviews my assessment, and does a licensed provider decide before any prescription is written? Which pharmacy will prepare my medication, in which state is it licensed, and will its name and contact details be on my label? Is the platform listed as certified on LegitScript’s checker? Is the product semaglutide base, and what is the vial’s concentration? Who explains the measuring, and who can I ask afterwards? What does the price include, does it change with dose, and what is refunded if the provider does not prescribe? Where are the cancellation terms published? A provider that answers all of those in writing is doing what the FDA and LegitScript describe.
Red flags the FDA names
From BeSafeRx: no prescription required, no United States license or state board license, no licensed pharmacist to answer questions, medicine that looks different or arrives damaged, expired or without an expiration date, prices too good to be true, charges for products never ordered, and no clear written protection of personal and financial information. From the GLP-1 statement: a claim that the compounded drug is the same as an FDA-approved drug, no screening by a licensed doctor, no doctor available afterwards, spelling errors or a wrong pharmacy address on the label, a pharmacy name that may be fraudulent, products sold as for research purposes or not for human consumption, and medicine that arrives warm, which the FDA says not to use. The statement also reports fraudulent labels naming pharmacies that do not exist or did not make the product.
Any one of these is a reason to stop. The FDA’s consumer guidance explains the stakes: medicine from unsafe sources may contain too much or too little active ingredient, the wrong ingredient, or harmful substances, and may have been stored without temperature control.
How to read a price
Prices for personalized compounded semaglutide programs look comparable and usually are not. Four questions make them so. What does the price include: assessment, provider review, messaging and medication, or only one of those? Does it change with dose, since the label’s escalation means the dose will change over months? What happens to your payment if the provider does not prescribe? And what are the cancellation terms for the plan you are choosing, especially a prepaid one? The cost guide on this site sets Bodi Envi’s published figures beside the manufacturer’s list price for Wegovy® so the difference between a program price and a medication price is visible.
A low price achieved by skipping a step, no provider review or no identifiable pharmacy, is not a saving; it is one of the FDA’s warning signs with a discount attached.
Bodi Envi as one labeled example
Against the checks above, Bodi Envi’s published statements are these. It is a LegitScript-certified U.S. telehealth platform and publishes a verification link to LegitScript’s checker for its domain on every page. It is not a medical practice, pharmacy or medication manufacturer. Clinical services for applicable programs are provided by Wasef Health, PC, whose licensed providers independently determine whether treatment is appropriate; completing an assessment does not guarantee a prescription. Prescriptions are dispensed by third party U.S. 503A licensed compounding pharmacies, VialsRx is the current pharmacy partner for applicable GLP-1 prescriptions, availability may vary by program and location, and the prescription label and care team confirm the pharmacy that applies. The personalized compounded semaglutide program is priced on the Plans page at $155 per month billed monthly, $145 on a three month plan, $135 on a six month plan and $125 on a twelve month plan, including the assessment, provider review, care team messaging, a GLP-1 ebook and diet plan, and the medication when prescribed, and pricing does not increase based solely on dosage strength. Cancellation and refunds are governed by the published refund policy. The care team can be messaged through the patient portal after the medication arrives.
Those are Bodi Envi’s own statements, given as an example of the checks answered in writing and not as a comparison with anyone. Apply the same checks to any provider, this one included. Personalized Compounded semaglutide is not FDA-approved and is not equivalent to Wegovy®; the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. This guide is general information and not medical advice, and a licensed provider decides whether treatment is appropriate for you.